Search Results

FastWave Completes Enrollment in FIH Study of Peripheral IVL System

January 17, 2024—FastWave Medical announced the completion of enrollment for the first-in-human (FIH) study of its peripheral intravascular lithotripsy (IVL) technology.

Bolton Medical Begins Phase 2 Trial for RelayPro to Treat Descending TAA

May 16, 2017—Bolton Medical announced that the first patient has been enrolled in the RelayPro US Food and Drug Administration (FDA) phase 2 clinical trial, which is designed to study the safety and effectiveness of the company's RelayPro thoracic stent graft system as a treatment for endovascular repair of descending thoracic aortic aneurysms (TAA).

FastWave’s IVL System FIH Study Reveals 30-Day Data

May 29, 2024—FastWave Medical announced the 30-day results of its first-in-human (FIH) study using the company’s peripheral intravascular lithotripsy (IVL) technology.

FastWave Announces Medical Advisor Appointments and Pipeline Update

March 6, 2024—FastWave Medical Inc., a device company focused the treatment of calcified cardiovascular disease through intravascular lithotripsy (IVL), recently announced the appointments of eight medical advisors.

Nectero Medical Raises Funds for Development of Platform to Treat Aneurysmal Disease

September 10, 2021—Nectero Medical Inc. announced the closing of its $19.5 million Series C financing round.

AngioScore Launches 100-mm AngioSculpt Balloon Catheters

September 6, 2011—AngioScore, Inc. (Fremont, CA) announced the launch of the 100-mm AngioSculpt percutaneous transluminal angioplasty (PTA) scoring balloon catheters for the treatment of peripheral artery disease.

Terumo Aortic Completes Enrollment of RelayPro United States Pivotal Trial

September 26, 2019—Terumo Aortic announced the completion of enrollment of the RelayPro pivotal trial in the United States.

AngioDynamics’ Auryon Atherectomy System Commercially Launched in the United States

September 21, 2020—AngioDynamics, Inc. announced the United States commercial launch of the Auryon atherectomy system for the treatment of peripheral artery disease (PAD), including critical limb ischemia (CLI) and in-stent restenosis (ISR).

Terumo Aortic’s RelayPro Thoracic Stent Graft System Introduced Commercially in United States

September 16, 2021—Terumo Aortic announced the first commercial implants in the United States of its RelayPro thoracic stent graft system, which was recently approved by the FDA for treatment of patients with fusiform and saccular aneurysms and penetrating atherosclerotic ulcers in the descending thoracic aorta.